Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1-pT3 bladder tumors

Annals of Oncology

Volumn 23, Issue 11, 2012, Pages 2948-2953

  Koning, C C E ^a   Blank, L E C M ^a   Koedooder, C ^a   van Os, R M ^a   van de kar, M ^a   Jansen, E ^a   Battermann, J J ^b   Beijert, M ^c   Gernaat, C ^d   van Herpen, K A M ^e   Hoekstra, C ^f   Horenblas, S ^g   Jobsen, J J ^d   Krol, A D G ^h   Lybeert, M L M ⁱ   van Onna, I E W ^j   Pelger, R C M ^h   Poortmans, P ^k   Pos, F J ^g   van der Steen Banasik, E ^l   Slot, A ^m   Visser, A ^l   Pieters, B R ^a   more..

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d MEDISCH SPECTRUM TWENTE   (Netherlands)

^e Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^f Radiotherapeutic Institute Stedendriehoek en Omstreken   (Netherlands)

^g ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ CATHARINA HOSPITAL   (Netherlands)

^j AMPHIA HOSPITAL   (Netherlands)

^k Institute Verbeeten   (Netherlands)

^l Arnhems Radiotherapeutisch Instituut   (Netherlands)

^m Radiotherapeutic Institute Friesland RIF   (Netherlands)

more..

Author keywords

Bladder cancer; Bladder preserving; Brachytherapy; Multicenter data

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER TUMOR; BRACHYTHERAPY; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CYSTECTOMY; CYSTOTOMY; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FISTULA; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; NECROSIS; NETHERLANDS; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RECURRENCE FREE SURVIVAL; TRANSURETHRAL RESECTION; TUMOR RECURRENCE; TUMOR VOLUME; ULCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; CYSTECTOMY; CYSTOTOMY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84868154675     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds126     Document Type: Article

References (27)

1. Visser O, Nieuwenhuijzen JA, Horenblas S. Local recurrence after cystectomy and survival of patients with bladder cancer: a population based study in greater amsterdam. J Urol 2005; 174: 97-102.
2. Gschwend JE, Dahm P, Fair WR. Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol 2002; 41: 440-448.
3. Gospodarowicz MK. Radiotherapy and organ preservation in bladder cancer: are we ignoring the evidence? J Clin Oncol 2002; 20: 3048-3050.
4. Henningsohn L, Steven K, Kallestrup EB, Steineck G. Distressful symptoms and well-being after radical cystectomy and orthotopic bladder substitution compared with a matched control population. J Urol 2002; 168: 168-174.
5. Khafagy M, Shaheed FA, Moneim TA. Ileocaecal vs ileal neobladder after radical cystectomy in patients with bladder cancer: a comparative study. BJU Int 2006; 97: 799-804.
6. Osman Y, bol-Enein H, Nabeeh A et al. Long-term results of a prospective randomized study comparing two different antireflux techniques in orthotopic bladder substitution. Eur Urol 2004; 45: 82-86.
7. Protogerou V, Moschou M, Antoniou N et al. Modified S-pouch neobladder vs ileal conduit and a matched control population: a quality-of-life survey. BJU Int 2004; 94: 350-354.
8. Rodel C, Grabenbauer GG, Kuhn R et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 2002; 20: 3061-3071.
9. Shipley WU, Zietman AL, Kaufman DS et al. Invasive bladder cancer: treatment strategies using transurethral surgery, chemotherapy and radiation therapy with selection for bladder conservation. Int J Radiat Oncol Biol Phys 1997; 39: 937-943.
10. Zietman AL, Grocela J, Zehr E et al. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder. Urology 2001; 58: 380-385.
11. Piet AH, Hulshof MC, Pieters BR et al. Clinical results of a concomitant boost radiotherapy technique for muscle-invasive bladder cancer. Strahlenther Onkol 2008; 184: 313-318.
12. Pos FJ, Hulshof M, Lebesque J et al. Adaptive radiotherapy for invasive bladder cancer: a feasibility study. Int J Radiat Oncol Biol Phys 2006; 64: 862-868.
13. van der Werf-Messing BH, Menon RS, Hop WC. Carcinoma of the urinary bladder category T2,T3 (NxM0) treated by the combination of radium implant and external irradiation: second report. Int J Radiat Oncol Biol Phys 1983; 9: 481-485.
14. van der Werf-Messing BH, van Putten WL. Carcinoma of the urinary bladder category T2,3NXM0 treated by 40 Gy external irradiation followed by cesium137 implant at reduced dose (50%). Int J Radiat Oncol Biol Phys 1989; 16: 369-371.
15. Breur K. [Radiotherapy of bladder carcinoma]. Ned Tijdschr Geneeskd 1956; 100: 1053-1062.
16. Blank LE, Koedooder K, van Os R et al. Results of bladder-conserving treatment, consisting of brachytherapy combined with limited surgery and external beam radiotherapy, for patients with solitary T1-T3 bladder tumors less than 5 cm in diameter. Int J Radiat Oncol Biol Phys 2007; 69: 454-458.
17. González González D, van der Veen J, Ypma AF et al. Brachytherapy for urinary bladder cancer. Arch Esp Urol 1999; 52: 655-661.
18. Pos F, Moonen L. Brachytherapy in the treatment of invasive bladder cancer. Semin Radiat Oncol 2005; 15: 49-54.
19. Pos F, Horenblas S, Dom P et al. Organ preservation in invasive bladder cancer: brachytherapy, an alternative to cystectomy and combined modality treatment? Int J Radiat Oncol Biol Phys 2005; 61: 678-686.
20. van der Steen-Banasik EM, Visser AG, Reinders JG et al. Saving bladders with brachytherapy: implantation technique and results. Int J Radiat Oncol Biol Phys 2002; 53: 622-629.
21. van der Steen-Banasik EM, Ploeg M, Witjes JA et al. Brachytherapy versus cystectomy in solitary bladder cancer: a case control, multicentre, East-Netherlands study. Radiother Oncol 2009; 93: 352-357.
22. van Onna I, Oddens JR, Kok ET et al. External beam radiation therapy followed by interstitial radiotherapy with iridium-192 for solitary bladder tumours: results of 111 treated patients. Eur Urol 2009; 56: 113-121.
23. Pernot M, Hubert J, Guillemin F et al. Combined surgery and brachytherapy in the treatment of some cancers of the bladder (partial cystectomy and interstitial iridium-192). Radiother Oncol 1996; 38: 115-120.
24. Rozan R, Albuisson E, Donnarieix D et al. Interstitial iridium-192 for bladder cancer (a multicentric survey: 205 patients). Int J Radiat Oncol Biol Phys 1992; 24: 469-477.
25. Van Poppel H, Lievens Y, Van Limbergen E, Baert L. Brachytherapy with iridium-192 for bladder cancer. Eur Urol 2000; 37: 605-608.
26. Pos FJ, Horenblas S, Lebesque J et al. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer. Int J Radiat Oncol Biol Phys 2004; 59: 696-705.
27. Wijnmaalen A, Boeken Kruger CC. Organ preservation by external beam and afterloading interstitial radiation in patients with muscle infiltrating bladder cancer. Semin Urol Oncol 2000; 18: 308-312.